Home Stock China imposes sanctions on US military firms over Taiwan arms deal

China imposes sanctions on US military firms over Taiwan arms deal

by
0 comment

China has imposed sanctions on 13 American military companies. This action is a direct response to the United States’ involvement in an arms deal with Taiwan.

The sanctions were confirmed by the Chinese foreign ministry, citing the recent authorization of a potential $385-million sale of military equipment to Taiwan as the primary reason for their decision.

The U.S. arms package includes spare parts and support for F-16 fighter jets and radars, a sale that China views as a violation of its sovereignty and territorial integrity.

China regards Taiwan as part of its territory and has expressed strong opposition to any form of interaction with foreign countries by Taiwan’s leadership, including President Lai Ching-te, whom Beijing considers a separatist.

Among the companies targeted by China’s sanctions are Teledyne Brown Engineering Inc, BRINC Drones Inc, and Shield AI Inc. The list extends to Rapid Flight LLC, Red Six Solutions, SYNEXXUS Inc, Firestorm Labs Inc, Kratos Unmanned Aerial Systems Inc, HavocAI, Neros Technologies, Cyberlux Corporation, Domo (NASDAQ:DOMO) Tactical Communications, and Group W.

These firms have been identified in connection with the U.S. arms sale to Taiwan, prompting the sanctions from China.

The U.S. government had facilitated transit through its territory for Taiwan’s president, an action that further strained relations with China and contributed to the imposition of these sanctions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

You Might Also Like
  • Charter rolls out new Spectrum pricing and internet speeds, aims to ‘be a better service operator’
  • Joby Aviation gains FAA certificates, advances air taxi plans
  • UniCredit says ready to sit down with Credit Agricole over Banco BPM
  • Federal Trade Commission accuses three drug middlemen of inflating insulin prices

You may also like